Daewon Pharmaceutical Co Ltd banner

Daewon Pharmaceutical Co Ltd
KRX:003220

Watchlist Manager
Daewon Pharmaceutical Co Ltd Logo
Daewon Pharmaceutical Co Ltd
KRX:003220
Watchlist
Price: 11 810 KRW -0.84% Market Closed
Market Cap: ₩264.9B

Daewon Pharmaceutical Co Ltd
Investor Relations

Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The Company’s products include antipyretics, analgesics, anti-inflammatory drugs, respiratory drugs, gastrointestinal drugs, antimicrobial drugs, cardiovascular drugs, metabolic drugs, psychoneurotic drugs, neuromuscular drugs, endocrine drugs and others. The firm also produces multivitamins and health foods. The firm distributes its products within domestic market and overseas markets, including Vietnam, Myanmar, Southeast Asia, the Middle East and others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Seung-Ryel Baek
Vice Chairman, CEO & President
No Bio Available

Contacts

Address
SEOUL
Seoul
386, Cheonho-daero, Seongdong-gu
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett